Thus, a cross-regulatory role of EGFR and EpCAM appears as a general regulatory mechanism that is instrumental in carcinoma cells and includes negative and positive feedback loops to control ERK1/2 and, ultimately, cell fate. The gene discussed is EGFR; the disease is carcinoma.